Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4286-4292

  Da Matta Guedes, Paulo Marcos ^a   Urbina, Julio A ^c   De Lana, Marta ^a   Afonso, Luis C C ^a   Veloso, Vanja M ^a   Tafuri, Washington L ^a   Machado Coelho, George L L ^a   Chiari, Egler ^b   Bahia, Maria Terezinha ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; BENZIMIDAZOLE; NIFURTIMOX; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HOST; IN VIVO STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; TOXICITY; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; MONOCYTES; NIFURTIMOX; NITROIMIDAZOLES; QUINAZOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 7244219956     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4286-4292.2004     Document Type: Article

References (38)

1. Ávila, H. A., A. M. Gonçalves, N. C. Nehme, and L. Simpson. 1990. Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences. Mol. Biochem. Parasitol. 42:175-188.
2. Ávila, H. A., D. S. Sigman, L. M. Cohen, R. C. Millikan, and L. Simpson. 1991. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolation from whole blood lysates: diagnosis of chronic Chagas' disease. Mol. Biochem. Parasitol. 40:211-222.
3. Bartrolí, J., E. Turmo, E. E. Algueró, M. L. Bomcompte, L. Vericat, J. Conte, J. Ramis, M. Merlos, J. Garcia-Rafanell, and J. Forn. 1998. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J. Med. Chem. 41:1869-1882.
4. Brener, Z. 1984. Recent advances in the chemoterapy of Chagas disease. Mem. Inst. Oswaldo Cruz 79:149-155.
5. Britto, C., M. A. Cardoso, P. Wincker, and C. M. A. Morel. 1993. Simple protocol for cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR) based diagnosis of chronic Chagas' disease. Mem. Inst. Oswaldo Cruz 88:171-172.
6. Cançado, J. R. 1980. Forma aguda da doença de Chagas no Brasil. Rev. Assoc. Med. Bras. 26:285-288.
7. Chiari, E., J. C. P. Dias, M. Lana, and C. A. Chiari. 1989. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev. Soc. Bras. Med. Trop. 22:19-23.
8. Dias, J. C. P., A. C. Silveira, and C. J. Schofield. 2002. The impact of Chagas disease control in Latin America. Mem. Inst. Oswaldo Cruz 97:603-612.
9. Docampo, R. 1990. Sensitivity of parasites to free radical damage by anti-parasitic drugs. Chem. Biol. Interact. 73:1-27.
10. Dutra, W. O., Z. M. Luz, J. R. Cançado, M. E. Pereira, R. M. Brigido-Nunes, L. M. C. Galvão, D. G. Colley, Z. Brener, G. Gazzinelli, and J. F. Carvalho-Parra. 1996. Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol. 18:579-585.
11. Ferreira, H. O. 1990. Tratamento da forma indeterminada da doenća de Chagas com nifurtimox e benznidazol. Rev. Soc. Bras. Med. Trop. 23:209-211.
12. Filardi, L. S., and Z. Brener. 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81:755-759.
13. Gomes, M. L., A. M. Macedo, A. R. Vago, S. D. J. Pena, L. M. C. Galvão, and E. Chiari. 1998. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp. Parasitol. 88:28-33.
14. Guedes, P. M. M., V. M. Veloso, W. L. Tafuri, L. M. C. Galvão, C. M. Carneiro, M. Lana, E. Chiari, K. A Soares, and M. T. Bahia. 2002. The dogs as model for chemoterapy of the Chagas disease. Acta Trop. 84:9-17.
15. Lana, M., and C. A. Chiari. 1986. Caracterizaçāo biológica comparativa das cepas Berenece-78 de Trypanosoma cruzi, isoladas da mesma paciente em diferentes períodes. Mem. Inst. Oswaldo Cruz 81:247-253.
16. Lazardi, K., J. A. Urbina, and W. de Souza. 1991. Ultrastructural alterations induced by ICI-195739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 35:736-740.
17. Liendo, A., K. Lazardi, and J. A. Urbina. 1998. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J. Antimicrob. Chemother. 41:197-205.
18. Molina, J. T., Z. Brener, J. A. Urbina, and A. J. Romanha. 2000. Activity of TAK-187 triazole on mice infected with Trypanosoma cruzi stains differently susceptible to benznidazole. Mem. Inst. Oswaldo Cruz 95:304-308.
19. Molina, J. T., O. A. Martins-Filho, Z. Brener, A. J. Romanha, D. Loebenberg, and J. A. Urbina. 2000. Activities of the triazole derivative SCH 56592 (posoconazole) against drug-resistant strains of the protozoan parasite Trypanosoma cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob. Agents Chemother. 44:150-155.
20. Rassi, A., and A. O. Luquetti. 1992. Therapy of Chagas disease, p. 237-247. In S. Wendel, Z. Brener, E. Camargo, and A. Rassi, (ed.), Chagas diseases (American trypanosomiasis): its impacts on transfusion and clinical medicine. ISBT, São Paulo, Brazil.
21. Rassi, A., V. Amato Neto, A. F. De Siqueira, F. Ferriolli Filho, V. S. Amato, and A. Rassi, Jr. 1999. Protective effects of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases. Rev. Soc. Bras. Med. Trop. 32:475-482.
22. Santos, F. R., S. D. J. Pena, and J. T. Epplen. 1993. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Hum. Genet. 90:655-656.
23. Schofield, C. J., and J. C. P. Dias. 1999. The Southern Cone Initiative against Chagas disease. Adv. Parasitol. 42:1-27.
24. Silva, L. H. P., and V. Nussenzweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20: 191-203.
25. Snedecor, G. W., and W. G. Cochran. 1989. Statistical methods, 8th ed. Iowa State University Press, Ames.
26. Suasnábar, F., E. Arias, and M. Streiger. 2000. Evolutive behaviour towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Rev. Inst. Med. Trop. São Paulo 42:99-109.
27. Toledo, M. J., M. T. Bahia. C. M. Carneiro, O. A. Martins-Filho, M. Tibayrenc, C. Barnabé, W. L. Tafuri, and M. Lana. 2003. Chemotherapy with benznidazole or itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrob. Agents Chemother. 47:223-230.
28. Urbina, J. A. 2002. Chemotherapy of Chagas disease. Curr. Pharm. Design 8:287-295.
29. Urbina, J. A., R. Lira, G. Visbal, and J. Bartroli. 2000. In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 44:2498-2502.
30. Urbina, J. A., E. Marchan, K. Lazardi., G. Visbal, R. Apitz-Castro, and F. Gil. 1993. Inhibition of phosphatidylcholine biosynthesis and cell proliferation in Trypanosoma cruzi by ajoene, an antiplatelet compound isolated from garlic. Biochem. Pharmacol. 45:2381-2387.
31. Urbina, J. A., G. Payares, L. M. Contreras, A. Liendo, C. Sanoja, J. Molina, M. M. Piras, R. Piras, N. Perez, P. Wincker, and D. Loebenberg. 1998. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 42:1771-1777.
32. Urbina, J. A., G. Payares, J. Molina, C. Sanoja, A. Liendo, K. Lazardi, M. M. Piras, N. Perez, P. Wincker, and J. F. Ryley. 1996. Cure of short-and long-term experimental Chagas disease using D0870. Science 273:969-971.
33. Urbina, J. A., G. Payares, C. Sanoja, J. Molina, R. Lira, Z. Brener, and A. J. Romanha. 2003. Parasitological cure of acute and chronic experimental Chagas disease using a long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int. J. Antimicrob. Agents 21:39-48.
34. Vanden Bossche, H., and P. Marichal. 1992. Azole antifungals mode of action, p. 25-40. In H. Yamaguchi, G. S. Kobayashi, and H. Takahashi (ed.), Recent progress in antifungal chemotherapy. Marcel Dekker, Inc., New York, N.Y.
35. Veloso, V. M., C. M. Carneiro, M. J. O. Toledo, M. Lana, E. Chiari, W. L. Tafuri, and M. T. Bahia. 2001. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem. Inst. Oswaldo Cruz 96:105-111.
36. Voller, A., D. E. Bidwell, and A. Bartlett. 1976. Enzyme immunoassays in diagnostic medicine. Theory and pratice. Bull. W. H. O. 53:55-65.
37. Wincker, P., C. Britto, J. B. Pereira, M. A. Cardoso, W. Oelemann, and C. M. Morel. 1994. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am. J. Trop. Med. Hyg. 51:771-777.
38. World Health Organization. 2002. Control of Chagas disease. Second Report of the WHO Expert Committee. Technical Report Series, no. 905. World Health Organization, Geneva, Switzerland.